ALTO-100 in Bipolar Disorder With Depression (BD-D)
Trial details
- Registry ID
- NCT06656416
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| ALTO-100 in Bipolar Disorder With Depression (BD-D)NCT06656416 | Alto Neuroscience | Phase 2 | Recruiting | 2027-09Estimated |
| Phase 2b Study of ALTO-100 in MDDNCT05712187 | Alto Neuroscience | Phase 2 | Completed | 2024-09-05Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |